Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Oxford Nanopore Technologies logo — Our goal is to enable the analysis of anything, by anyone, a...

Oxford Nanopore Technologies

Our goal is to enable the analysis of anything, by anyone, anywhere.

Founded 2005 United Kingdom Oxford, United Kingdom 1341 employees Post-IPO Equity Total: $1.06B Biopharma, Biotechnology +1

General Information

Company Name Oxford Nanopore Technologies
Founded Year 2005
Location United Kingdom Oxford, United Kingdom
Founders / Decision Makers
Team member Team member
Employees 1341
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post-IPO Equity
Business Model B2B, D2C, Platform
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Oxford Nanopore Technologies. To contact Oxford Nanopore Technologies, visit nanoporetech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Oxford Nanopore Technologies compare?

A PDF of Oxford Nanopore Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Oxford Nanopore Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Oxford Nanopore Technologies

Oxford Nanopore Technologies, founded in 2005 as a spin-out from the University of Oxford, is a leader in the Biopharma, Biotechnology, and Health Care industries. The company's mission, encapsulated in their slogan—“Our goal is to enable the analysis of anything, by anyone, anywhere”—reflects their innovative approach in disrupting biological analysis.

The firm's flagship offering is the world’s first nanopore DNA and RNA sequencing platform, renowned for its real-time data delivery and scalability from portable to ultra-high throughput formats. This technological edge allows for unprecedented rapid insights and applications across the globe, reaching over 100 countries.

Headquartered in the United Kingdom, Oxford Nanopore employs a diverse team of over 600 experts. Recently, the company secured a £50.00M Post-IPO Equity investment from Novo Holdings in August 2024, underscoring strong investor confidence under the helm of CEO Dr. Gordon Sanghera.

Business keywords: nanopore sequencing, DNA sequencing, RNA sequencing, portable sequencing devices, real-time data delivery, molecular biology, genomics, cancer research, microbiology, plant science, environmental research, healthcare applications, scalable sequencing solutions, bioinformatics

Services & Products

Sequencing Technology and Equipment
Data Analysis and Bioinformatics Tools
Training and Support Packages
Consultation for Sequencing Applications

Target Customers

Biopharmaceutical Companies Research Institutions Environmental Researchers Clinical Laboratories Educational Institutions Sequencing Service Providers

Funding Rounds & Investors (20)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity £50.00M 1
Novo Holdings
Novo Holdings
01 Aug 2024
Post IPO Equity £70.00M 1
bioMerieux
20 Oct 2023
Venture Round £195.00M 5
IP Group Temasek Holdings Wellington Management
IP Group, Temasek Holdings +3
04 May 2021
Series H £84.40M 3
Casdin Capital Railpen
Casdin Capital, Railpen +1
13 Oct 2020
Venture Round £48.40M -
26 May 2020
Secondary Market £109.50M -
04 Jan 2020
Venture Series Unknown Undisclosed -
18 Oct 2018
Venture Round £100.00M 3
GIC CCB International Hostplus
GIC, CCB International +1
20 Mar 2018
Venture Round £100.00M 2
IP Group GT Healthcare Capital Partners
IP Group, GT Healthcare Capital Partners
12 Dec 2016
Venture Round £70.00M 1
IP Group
IP Group
20 Jul 2015

View All 20 Funding Rounds

Latest News

View All
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of... — Nature.com
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities
Nature.com Sep 29, 2025
August 2024's top 10 European tech deals you need to know about — Tech
August 2024's top 10 European tech deals you need to know about
Tech Sep 06, 2024
M&G invests in biotech firm Nuclera — Funds-europe.com
M&G invests in biotech firm Nuclera
Funds-europe.com Feb 03, 2022

Oxford Nanopore Technologies Alternatives & Competitors

View All Alternatives
Oxford Nanopore Technologies vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care
Compare Oxford Nanopore Technologies vs OncoDNA
Oxford Nanopore Technologies vs
PhiTech
PhiTech Turkey

Multi-omics AI for Precision Medicine

27 employees
Biopharma, Biotechnology
Oxford Nanopore Technologies vs
BMR Genomics
BMR Genomics Italy

Empowering Research, Enhancing Lives Through Genomics.

20 employees
Biotechnology, Health Care
Also compare with: Oxford Nanopore Technologies vs TwinStrand Biosciences TwinStrand Biosciences View all alternatives

FAQ About Oxford Nanopore Technologies

Our goal is to enable the analysis of anything, by anyone, anywhere.
Oxford Nanopore Technologies was founded in 2005.
Oxford Nanopore Technologies is headquartered in Oxford, United Kingdom.
Oxford Nanopore Technologies operates in Biopharma, Biotechnology and Health Care. Its work centres on nanopore sequencing, DNA sequencing, RNA sequencing and portable sequencing devices. Its customers include Biopharmaceutical Companies, Research Institutions and Environmental Researchers.
Oxford Nanopore Technologies has a B2B, D2C and Platform business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Oxford Nanopore Technologies has approximately 1341 employees.
Oxford Nanopore Technologies has completed 20 funding rounds, raising a total of $1.06B. The latest funding stage is Post-IPO Equity.
Oxford Nanopore Technologies offers: Sequencing Technology and Equipment, Data Analysis and Bioinformatics Tools, Training and Support Packages, Consultation for Sequencing Applications.
Top alternatives and competitors to Oxford Nanopore Technologies include OncoDNA, PhiTech, BMR Genomics, GenoScreen, AVESTHAGEN LIMITED. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oxford Nanopore Technologies and OncoDNA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Oxford Nanopore Technologies, https://bouncewatch.com/company/oxford-nanopore-technologies, updated 10 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes